There are several reports, showing alterations in levels of circulating MANF/CDNF in patients with diabetes [36], autoimmune diseases (rheumatoid arthritis and systemic lupus erythematosus) [37], PD [38] and stroke [39]. This evidence concerns the gene CDNF and stroke disorder.